AAWHAscend Wellness Holdings, Inc.
The schedule
- Wed30Sep
Given the persistent cash burn, there is a material risk of a dilutive equity offering or structured financing event to shore up liquidity ahead of Q4.
- Sat31Oct
Updates on dispensary license awards and the opening of new state-level retail locations to drive top-line volume.
- Mon9Nov
Management will provide Q3 operational results alongside initial framing for the 2027 fundamental and capital expenditure outlook.
- Sun31Jan
Market pricing of federal legislative reform, including potential DEA rescheduling or banking adjustments under the Trump administration.
- Sun14Feb
- Wed12May
Past
- Wed5Aug
Actual outcome: Bull · $0.48 at outcome
Stock rose 17.1% from event to outcome date, aligning with the bull trajectory.
- Tue30Jun
Actual outcome: Bear · $0.44 at outcome
Ascend Wellness announced it filed DEA registration applications for state-licensed medical cannabis operations, but failed to provide the anticipated updates on balance sheet optimization or operational efficiencies. Without concrete steps to address its substantial quarterly cash burn, investor confidence waned, driving the stock down 10.2% to breach the bear floor.
Ascend Wellness is expected to provide updates on operational efficiencies and potential interest optimization to address its substantial quarterly cash burn.
- Wed13May
Actual outcome: Bear · $0.52 at outcome
Stock fell 8.5% from event to outcome date, aligning with the bear trajectory.
First 2026 earnings update for Ascend Wellness Holdings, with investors focused on reversing the recent revenue contraction, sustaining positive free cash flow, and any commentary on debt service and state-level growth.
